Strata Critical Medical, Inc. (SRTA)
(Delayed Data from NSDQ)
$4.06 USD
-0.12 (-2.87%)
Updated Sep 5, 2025 04:00 PM ET
After-Market: $4.06 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
SRTA 4.06 -0.12(-2.87%)
Will SRTA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SRTA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SRTA
The Zacks Analyst Blog Highlights Joby Aviation, Archer Aviation and Strata Critical Medical
JOBY's Premium Valuation: Should You Buy, Sell or Hold the Stock Now?
SRTA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SRTA
50 Day Moving Average Resistance appears for SRTA after 2.87% move
SRTA forms 20 Day Moving Average Resistance on September 4
20 Day Moving Average Resistance appears for SRTA after 2.58% move
50 Day Moving Average Support appears for SRTA after 2.52% move
Strata Critical Medical to Present at the 2025 Jefferies Industrials Conference | SRTA Stock News